pubmed-article:17523929 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17523929 | lifeskim:mentions | umls-concept:C1123023 | lld:lifeskim |
pubmed-article:17523929 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17523929 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:17523929 | lifeskim:mentions | umls-concept:C0011615 | lld:lifeskim |
pubmed-article:17523929 | lifeskim:mentions | umls-concept:C0039198 | lld:lifeskim |
pubmed-article:17523929 | lifeskim:mentions | umls-concept:C0205246 | lld:lifeskim |
pubmed-article:17523929 | lifeskim:mentions | umls-concept:C0392760 | lld:lifeskim |
pubmed-article:17523929 | pubmed:issue | 2-3 | lld:pubmed |
pubmed-article:17523929 | pubmed:dateCreated | 2007-5-25 | lld:pubmed |
pubmed-article:17523929 | pubmed:abstractText | Regulatory T cells (T-reg cells) have been described as an important cell population in the UV treatment of inflammatory skin diseases. | lld:pubmed |
pubmed-article:17523929 | pubmed:language | eng | lld:pubmed |
pubmed-article:17523929 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17523929 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17523929 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17523929 | pubmed:issn | 0905-4383 | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:RoldánM RMR | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:MempelMartinM | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:SchnoppChrist... | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:RingJohannesJ | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:OllertMarkusM | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:WeidingerStef... | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:EberleinBerna... | lld:pubmed |
pubmed-article:17523929 | pubmed:author | pubmed-author:WeidingerAnke... | lld:pubmed |
pubmed-article:17523929 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17523929 | pubmed:volume | 23 | lld:pubmed |
pubmed-article:17523929 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17523929 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17523929 | pubmed:pagination | 81-5 | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:meshHeading | pubmed-meshheading:17523929... | lld:pubmed |
pubmed-article:17523929 | pubmed:articleTitle | Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy. | lld:pubmed |
pubmed-article:17523929 | pubmed:affiliation | Department of Dermatology and Allergy, Biederstein, Technical University Munich, Munich, Germany. | lld:pubmed |
pubmed-article:17523929 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17523929 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |